CON
CON: DiCanio Matthew T. discloses securities transactions
DiCanio Matthew T. reported Tax/exercise withholding in Concentra Group Holdings Parent, Inc.: 35416 units of Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
CON
DiCanio Matthew T. reported Tax/exercise withholding in Concentra Group Holdings Parent, Inc.: 35416 units of Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
CON
Devasia Thomas A. reported Tax/exercise withholding in Concentra Group Holdings Parent, Inc.: 11806 units of Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
CRSP
Sakhamuri Sivakesava reported Grant or award in CRISPR Therapeutics AG: 90000 units of Stock Option (Right to Buy) (derivative), dated 2026-11-04. The full Form 4 contains 2 transaction entries.
EXTR
PASEK RONALD J reported Exercise or conversion in EXTREME NETWORKS INC: 11075 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
AGYS
Badger Kyle C reported Grant or award in AGILYSYS INC: 3099 units of Restricted Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
EXTR
KENNEDY EDWARD H reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
EXTR
Burton Ingrid reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
EXTR
HOLMGREN KATHLEEN M reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
JOF
Saba Capital Management, L.P. reported Purchase in JAPAN SMALLER CAPITALIZATION FUND INC: 28208 units of Common Stock, dated 2026-11-05. The full Form 4 contains 1 transaction entry.
EXTR
Khanna Raj reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
EXTR
Shoemaker John C reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
LEVI
Prime Joshua E reported 111 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
EXTR
Carinalli Charles reported Exercise or conversion in EXTREME NETWORKS INC: 11767 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
LEVI
Patrick Artemis reported 72 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
PETS
KRULIK DOUGLAS reported Tax/exercise withholding in PETMED EXPRESS INC: 3246 units of Common Stock, dated 2025-09-27. The full Form 4 contains 4 transaction entries.
LEVI
MING JENNY J reported Grant or award in LEVI STRAUSS & CO: 57 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
GILD
O'Day Daniel Patrick reported Exercise or conversion in GILEAD SCIENCES, INC.: 102619 units of Common Stock, dated 2026-11-04. The full Form 4 contains 6 transaction entries.
LEVI
MARBERGER DAVID S reported 77 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
AGYS
Shivashankar Sethuram reported Grant or award in AGILYSYS INC: 4848 units of Restricted Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
LEVI
Jones Jeffrey J II reported 71 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
LEVI
Geballe Daniel W reported 137 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
LEVI
Garten Yael reported 163 shares of Class A Common Stock in LEVI STRAUSS & CO as grants or awards dated 2026-11-04. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
LEVI
Beraud Jill reported Grant or award in LEVI STRAUSS & CO: 57 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
JAZZ
Carr Patricia reported Exercise or conversion in Jazz Pharmaceuticals plc: 1250 units of Ordinary Shares, dated 2026-11-04. The full Form 4 contains 4 transaction entries.